As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain widespread use for weight loss, medical professionals are noting a significant increase in patients seeking procedures to address loose skin resulting from rapid weight loss. Dr. Ben Schalet, a specialist at Albany Med, reports receiving multiple requests each week for skin-tightening surgeries, particularly targeting the abdomen, face, neck, arms, and thighs.
“The demand is overwhelming; it seems like every day we are consulted by someone asking about options for tightening loose skin,” Dr. Schalet shared.
These procedures, while largely cosmetic and not typically covered by insurance, can sometimes be eligible for coverage if the loose skin leads to medical issues such as rashes or infections. In such cases, insurance may approve surgery as a necessary medical treatment. For many patients, additional cosmetic work is also sought to address other areas where skin has lost elasticity.
The cost of skin tightening surgeries varies widely, ranging from $10,000 to $25,000, which includes anesthesia and facility fees. Dr. Schalet recommends that individuals considering GLP-1 medications for weight loss set aside funds for potential skin surgery, given that skin elasticity can be affected by age, the extent of weight loss, and individual skin characteristics. “Skin elasticity can be influenced by a variety of factors, and in cases where skin doesn’t contract effectively, surgery may offer the best results,” he explained.
The growing interest in skin surgeries among GLP-1 users echoes a similar trend that emerged following bariatric surgery, where patients also faced challenges with excess skin after significant weight loss.
In parallel with the rise in surgical consultations, researchers are investigating additional benefits of GLP-1 medications. Early studies suggest these drugs may reduce the risks associated with substance use disorders, mental health conditions like depression and psychosis, as well as other issues such as seizures, clotting, and fatty liver disease. However, as these medications are still relatively new, concerns about side effects—ranging from nausea and low blood pressure to kidney complications and sleep disturbances—persist, warranting further investigation to fully assess their long-term impact.
Related Topics:
